Strengthening the DOTS Strategy and Improving the National Tuberculosis Programme (NTP), including Multidrug Resistant and Infection Control, in Bosnia and Herzegovina (BiH)

What is the project about?

 Opening of reconstructed laboratories for diagnosis of tuberculosis
Opening of reconstructed laboratories for diagnosis of tuberculosis

About one third of the world’s population is infected with tuberculosis (TB) bacteria, however only a small proportion of those infected will become sick with TB. Up to 20 million lives have been saved since 1995 through the DOTS (Directly Observed Treatment Short-course) and the Stop TB Strategies. Bosnia and Herzegovina is categorised as having an “intermediate” tuberculosis (TB) burden, with approximately 1,400 new tuberculosis cases reported annually over the last few years and a TB-related mortality rate of 6.8%. The majority of TB patients in Bosnia and Herzegovina can be cured with TB drugs as part of the standard treatment course, while resistance to those drugs is rare. Bosnia and Herzegovina has excellent treatment success results with more than 90% of TB patients reportedly cured. Therefore, it is quite probable that the Millennium Development Goal of reversing the tuberculosis epidemic by 2015 will be achieved in BiH. The UNDP project is working towards achieving this goal, with activities aimed at ensuring access to diagnosis, treatment and care for all people affected by TB.

What we do?

The project activities include the following:

  • Ensuring Health Care Management Units dealing with tuberculosis are established at all administrative levels across the country;
  • Procuring essential laboratory equipment for TB laboratories dealing with the diagnosis of tuberculosis in BiH, ensuring the application of safety and quality standards, and improving patient access to standard and advanced diagnostic procedures;
  • Supporting the implementation of infection control policies and practices, leading to the prevention of new TB cases through timely diagnosis, appropriate treatment of tuberculosis resistant to commonly used TB drugs, and preventing the transmission of resistant bacterial strains;
  • Strengthening the health system to provide adequate health care for the most vulnerable and marginalised groups in BiH society, such as the Roma population. These actions have been reinforced by the establishment of a system of TB community care and by supporting NGO’s in their efforts to promote appropriate health care access, and in their advocacy, communication and social mobilisation endeavours.

What have we accomplished so far?



 Opening of reconstructed laboratories for diagnosis of tuberculosis
Opening of reconstructed laboratories for diagnosis of tuberculosis
  • Tuberculosis cases reduced from 2,373 in 2007 to 1,413 in 2012;
  • Substantial progress achieved in tuberculosis control, in terms of improved TB case detection, the uninterrupted supply of anti-TB drugs for all TB patients free of charge; and a TB laboratory network that has been strengthened and regionalised with a comprehensive system of recording and reporting, forming part of an effective monitoring and evaluation mechanism

Continued action

UNDP BiH, in its capacity of a Principal Recipient for the Global Fund to Fight TB, HIV/AIDS and Malaria (GFATM) continues to seek ways to cost-effectively reduce the burden of disease of TB in BiH. The key principle of the project is the participatory involvement of the major health institutions in meeting its goals. The expected final outcomes are: high quality and easily accessible TB services, strengthened monitoring and evaluation and reliable recording and reporting systems, with a laboratory network enhanced in accordance with European standards, keeping bio-safety and quality assurance as a priority.

Who Finances it?

DONOR

AMOUNT CONTRIBUTED

2010

GFATM*

$ 854,148.77

2011

GFATM

$ 4,050,579.22

2012

GFATM

$ 5,864,149.95

*The Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM)

Delivery in previous fiscal year

DEC 2012

   $ 3,527,335.53

DEC 2011

   $ 2,652,262.37

DEC 2010

   $ 408,784.66

Geographic coverage

Overview
Status:
Active
Project start date:
10/01/2007
Estimated end date:
09/30/2015
Geographic coverage:
Bosnia and Herzegovina
Focus Area:
Social Inclusion and Democratic Governance
Project Manager:
Jasmina Islambegovic
Partners:
BiH Ministry of Civil Affairs, Federal Ministry of Health, Ministry of health and Social Welfare of Republika Srpska, NGO World Vision, Red Cross Society Bosnia and Herzegovina, Department for Health and other services of the Government of Brčko District
Donor
Stop TB Partnership - Infographics
Flyer

 

Related Publications
Framework Plan for Tuberculosis Prevention and Control in Healthcare Facilities in Bosnia and Herzegovina

Tuberculosis (TB), along with HIV/AIDS, is the most important infectious disease. According to the World Health Organisation, 8.8 million persons suffer from TB and 1.4 million deceased from TB in 2010.

The PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis

Although the large majority of tuberculosis cases worldwide are drug susceptible, multidrug-resistant tuberculosis (MDR TB) presents an emerging threat to global tuberculosis control.

TB Tips

Advice for People with Tuberculosis,  is a quick reference guide for patients. It is based on theframework-plan-for-tuberculosis-prevention-andframework-plan-for-tuberculosis-prevention-andframework-plan-for-tuberculosis-prevention-and popular tips that originally appeared in the first edition of "The Tuberculosis Survival Handbook".

Related documents